IGFBP7 expression has been shown to be inversely correlated with tumour grade and stage in hepatocellular carcinoma and lung cancer, and has been associated with favourable outcomes in breast, pancreatic, colorectal and liver cancer patients [26,35-38,40,42,44,45]. Here, IGFBP7 is linked to liver cancer.